Press "Enter" to skip to content

New patent for Alkermes Inc drug ARISTADA

2
Copyright © DrugPatentWatch. Originally published at New patent for Alkermes Inc drug ARISTADA

Annual Drug Patent Expirations for ARISTADA
Annual Drug Patent Expirations for ARISTADA

Aristada is a drug marketed by Alkermes Inc and is included in two NDAs. It is available from one supplier. There are eleven patents protecting this drug.

This drug has ninety-two patent family members in twenty-six countries.

The generic ingredient in ARISTADA is aripiprazole lauroxil. One supplier is listed for this compound. Additional details are available on the aripiprazole lauroxil profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Alkermes Inc drug ARISTADA
Online Certificate Course

Decision-Making for Generic Drug Entry & Branded Drug Lifecycle Management

  • When will key drug patents expire?
  • How can I find, evaluate, and plan for generic market entry opportunities?
  • How can I find proprietary out-of-court settlements and deal terms?
DrugPatentWatch - Make Better Decisions